What about immune side effects?

Hannah notes absence of CRS or ICANS in the phase one trial, differentiating this from CAR T cell toxicities.

Play episode from 23:43

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!